Balanced news tone
News Sentiment
CGEN sentiment intelligence
Compugen news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
42 relevant articles
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-1.5% over one week, -28.2% over four weeks, trend active, and near fair-value range.
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Earnings
76/100 classification
One-week reaction
-1.5%
Price digesting
Trend fit
Trend active
-28.2% over four weeks
Fair value
15.9%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
32
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
PR Newswire
Direct company coverage
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 11:00
- Source
- PR Newswire
Stock Titan
Direct company coverage
Compugen spotlights COM701 ovarian trial at ESMO congress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 11:00
- Source
- Stock Titan
TradingKey
Direct company coverage
Compugen Ltd (CGEN) Institutional Confidence
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:06
- Source
- TradingKey
Market source
Direct company coverage
Compugen (CGEN) Stock Faces Mixed Analyst Target Changes After Cautious Valuation Revisions
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Jun 2026 04:39
- Source
- Market source
TradingKey
Direct company coverage
Compugen Ltd (CGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 17 Jun 2026 20:57
- Source
- TradingKey
TradingKey
Direct company coverage
Compugen Ltd (CGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk
- Tone
- Negative 5/100
- Event
- Market update
- Published
- 17 Jun 2026 20:25
- Source
- TradingKey
PR Newswire
Direct company coverage
Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 11:00
- Source
- PR Newswire
PR Newswire
Direct company coverage
Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 11:00
- Source
- PR Newswire
Stock Titan
Direct company coverage
[EFFECT] COMPUGEN LTD SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Why The Narrative Around Compugen (NasdaqCM:CGEN) Is Shifting After Analyst Resets And New Views
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 03 Jun 2026 07:00
- Source
- Market source
GuruFocus.com
Direct company coverage
Compugen Ltd (CGEN) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 May 2026 01:01
- Source
- GuruFocus.com
simplywall.st
Direct company coverage
Compugen (CGEN) Returns To Loss In Q1 2026 And Tests Bullish Profitability Narrative
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- simplywall.st
MarketBeat
Direct company coverage
Compugen Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 May 2026 14:08
- Source
- MarketBeat
Associated Press
Direct company coverage
Compugen: Q1 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 May 2026 11:58
- Source
- Associated Press
Investing.com
Direct company coverage
Earnings call transcript: Compugen’s Q1 2026 revenue beats forecast, stock rises
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 May 2026 07:00
- Source
- Investing.com
Stock Titan
Direct company coverage
Compugen Ltd. (NASDAQ: CGEN) files $400M shelf; $100M ATM with Leerink
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Stock Titan
Quiver Quantitative
Direct company coverage
COMPUGEN ($CGEN) Releases Q1 2026 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 May 2026 07:00
- Source
- Quiver Quantitative
Market source
Direct company coverage
Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 18 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Compugen surges after revenue tops forecasts despite quarterly loss miss (CGEN)
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 18 May 2026 07:00
- Source
- Market source
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Cancer immunotherapy firm Compugen joins Stifel oncology forum
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Stock Titan
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Compugen sets May 18 earnings release, 8:30 AM ET webcast
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- Stock Titan
newsline.com
Direct company coverage
What is the outlook for Compugen (CGEN) stock today (Climbs Higher) 2026-04-27 - Bollinger Expansion
- Tone
- Positive 82/100
- Event
- Guidance
- Published
- 27 Apr 2026 07:00
- Source
- newsline.com
Stock Titan
Direct company coverage
Affiliate sells and proposes sales at CGEN (NASDAQ: CGEN) — 4,000 shares planned
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Ophir Eran plans resale of 5,000 shares (Nasdaq: CGEN)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Stock Titan
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Compugen management takes virtual Needham healthcare stage April 13
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- Stock Titan